Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

NVS 103.85 -0.94 (-0.90%)
price chart
Technical Insights on Novartis AG (ADR) (NYSE:NVS)
[Bloomberg] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) the world's biggest drugmaker by sales, reported first-quarter profit that beat analysts' estimates as the company begins to benefit from a set of transactions that make it smaller and more ...
Novartis AG (ADR) (NVS) Seeks $2-5 Billion Takeover Targets  Bidness ETC
Novartis AG's (ADR) (NYSE:NVS) (ADR) Looking For Buyout in the Range of ...  WallStreetPR (blog)
Novartis AG (ADR) Partners With Aduro Biotech With A $750 Million Deal
Novartis AG (ADR) (NYSE:NVS) has announced a deal with cancer immunotherapy company, Aduro Biotech, Inc., in which both the companies will partner to research and manufacture treatments for cancer.
Novartis AG (ADR) Inks $750 Million Deal With Aduro Biotech  Bidness ETC
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD) and Novartis AG (ADR ...
The stake in Novartis AG (ADR) (NYSE:NVS) increased to 63,268 shares in 1Q from 59,083 shares in 4Q. The new stake was worth $6.2 million at the end of the latest quarter, representing a decent improvement in dollar value from $5.5 million in the ...
Novartis AG (ADR) CAR-T Drug Delays Cancer Progress
Novartis AG (ADR) (NYSE:NVS) has been actively seeking to establish a strong foothold in the highly lucrative immune-oncology drug market.
Stock To Watch : Novartis AG (ADR)(NYSE:NVS)
Novartis AG (ADR)(NYSE:NVS) (TREND ANALYSIS) shares are still trading near the 52-week high of $102.59. The stock closed last trading session at $101.48, with a volume of 1,334,174 shares against an average volume for the last 3 months of 1,498,780.
Novartis AG (ADR) Biosimilar Blocked By US Appeals Court
The US Appeals court has blocked Novartis AG (ADR) (NYSE:NVS) from selling a copy of Amgen, Inc.'s (NASDAQ:AMGN) cancer supportive-care drug in the US for an indefinite period of time - or at least until June 3, when verbal arguments are scheduled, ...
Gender Discrimination Lawsuit Filed Against Novartis AG (ADR)(NYSE:NVS)
There are various allegations of Sexual discrimination against Novartis AG (ADR) (NYSE:NVS)and it will have to defend itself against them in US courts.
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS), Sanofi SA (ADR ...
The stocks include London-based GlaxoSmithKline plc (ADR) (NYSE:GSK), Switzerland-based Novartis AG (ADR) (NYSE:NVS) and France-based Sanofi SA (ADR) (NYSE:SNY).
GlaxoSmithKline scraps HIV spinout, reports higher Q1 profit  Proactive Investors USA & Canada
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Unveils Big Business Growth Targets  WallStreetPR (blog)
What The EU's Approval For Zykadia Means For Novartis AG (ADR) (NVS)
Novartis AG ADR (NYSE:NVS) announced today that it has secured approval from European health regulators for Zykadia (ceritinib), a drug developed to treat advanced lung cancer in patients suffering from a certain genetic abnormality.
AstraZeneca plc (ADR), Novartis AG Combo Melanoma Drug Deemed Safe In ...
AstraZeneca plc (ADR) (NYSE:AZN) and Novartis AG (ADR) (NYSE:NVS) have partnered up to develop a three-drug combination treatment for a life-threatening form of skin cancer, melanoma.